Quest Diagnostics
DGX
$145.47
Share price
-2.13%
Change (1 day)
7.03%
Change (1 year)
Categories
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.
Number of shares outstanding for Quest Diagnostics (DGX)
Number of shares outstanding as of February 2023 : 116,000,000
According to Quest Diagnostics 's latest financial reports and stock price the company's current number of shares outstanding is 116,000,000. At the end of 2022 the company had 116,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Quest Diagnostics from 2001 to 2022
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2022 | 0.11 B | -4.92% |
| 2021 | 0.12 B | -9.63% |
| 2020 | 0.13 B | 0.75% |
| 2019 | 0.13 B | -1.47% |
| 2018 | 0.13 B | |
| 2017 | 0.13 B | -1.45% |
| 2016 | 0.13 B | -3.5% |
| 2015 | 0.14 B | -1.38% |
| 2014 | 0.14 B | -0.68% |
| 2013 | 0.14 B | -8% |
| 2012 | 0.15 B | 0.57% |
| 2011 | 0.15 B | -8.89% |
| 2010 | 0.17 B | -6.43% |
| 2009 | 0.18 B | -5.06% |
| 2008 | 0.19 B | 0.82% |
| 2007 | 0.19 B | -1.92% |
| 2006 | 0.19 B | -2.72% |
| 2005 | 0.20 B | 100.19% |
| 2004 | 0.10 B | -3.38% |
| 2003 | 0.10 B | 8.14% |
| 2002 | 96.9 M | 3.77% |
| 2001 | 93.38 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 LabCorp LH | 90,200,000 | -99.91% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | 62,908,800 | N/A | 🇺🇸 USA |
 Psychemedics PMD | 5,638,000 | -99.92% | 🇺🇸 USA |
 NeoGenomics
NEO | 124,425,000 | -99.80% | 🇺🇸 USA |
 Qiagen QGEN | 227,753,000 | -99.68% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | 48,720,000 | -99.96% | 🇺🇸 USA |